{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T22:08:04Z","timestamp":1750284484581,"version":"3.40.5"},"reference-count":30,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T00:00:00Z","timestamp":1729123200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Healthc Risk Manag"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Using pharmacy claims data from a single commercial health plan to identify opportunities for opioid use disorder (OUD) focused screening and interventions communicated via targeted prescriber messaging. Participants included members \u226518 years using more than 90 morphine milligram equivalents (MMED) daily based on all opioid claims, had &gt;1 paid claim for an opioid product, and had \u226590 days of total opioid therapy. Members were excluded with \u22651 claims for an oral chemotherapy agent (except methotrexate). Intervention was completed with a secure communication to the primary outpatient opioid prescriber that included resources for diagnosis, treatment, and best practices for opioid prescribing. The main outcome measure was any documented change to opioid use following the intervention. Seven hundred forty\u2010five members were identified; a subset (<jats:italic>n<\/jats:italic> = 20) was further assessed, and all had identified OUD risk factors; providers were subsequently sent a communication. Sixteen providers acknowledged receipt and 11 patients (55%) had at least one documented intervention following communication receipt. Provision of targeted, evidence\u2010based recommendations to providers for patients identified to be at risk of OUD from pharmacy claims data can result in increased recognition and intervention. Future efforts to explore feasibility of provider education detailing efforts and continued evaluation of efficacy are needed.<\/jats:p>","DOI":"10.1002\/jhrm.21585","type":"journal-article","created":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T16:23:54Z","timestamp":1729182234000},"page":"14-19","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Identification of patients on chronic prescription opioids at risk for opioid use disorder using pharmacy claims data"],"prefix":"10.1002","volume":"44","author":[{"given":"Aleesha","family":"Jantzen","sequence":"first","affiliation":[{"name":"Department of Pharmacy Regions Hospital  St. Paul Minnesota USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2299-5593","authenticated-orcid":false,"given":"Scott Thomas","family":"Hall","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Mayo Clinic Health System \u2013 La Crosse  La Crosse Wisconsin USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Lai","sequence":"additional","affiliation":[{"name":"Department of Family Medicine Mayo Clinic  Rochester Minnesota USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie L.","family":"Cunningham","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Mayo Clinic  Rochester Minnesota USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Odell","sequence":"additional","affiliation":[{"name":"Supply Chain Management Mayo Clinic  Rochester Minnesota USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2024,10,17]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.j.pain.0000460357.01998.f1"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13011\u2010017\u20100120\u20107"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000606"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.3365"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1507771"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.15909"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1370\/afm.2648"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n784"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pnz356"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.7326\/M22\u20102917"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228\u2010020\u201003026\u20104"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S295461"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/AJP.0000000000000021"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.8782"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100592"},{"key":"e_1_2_8_17_1","unstructured":"Medications for the Treatment of Opioid Use Disorder. Vol89;2024:7528\u20107563. Accessed August 30 2024.https:\/\/www.federalregister.gov\/documents\/2024\/02\/02\/2024\u201001693\/medications\u2010for\u2010the\u2010treatment\u2010of\u2010opioid\u2010use\u2010disorder"},{"key":"e_1_2_8_18_1","doi-asserted-by":"crossref","unstructured":"Wanzhen GaoP Cassandra LeightonP YiMin ChenP Jim JonesMBA Parul MistryMD.Predicting Opioid Use Disorder and Associated Risk Factors in a Medicaid Managed Care Population.2021;27. Accessed September 6 2023.https:\/\/www.ajmc.com\/view\/predicting\u2010opioid\u2010use\u2010disorder\u2010and\u2010associated\u2010risk\u2010factors\u2010in\u2010a\u2010medicaid\u2010managed\u2010care\u2010population","DOI":"10.37765\/ajmc.2021.88617"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.2217\/pmt\u20102020\u20100013"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606\u2010022\u201007975\u20107"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2015.1025"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2017.1309"},{"issue":"2","key":"e_1_2_8_23_1","first-page":"97","article-title":"Fourth wave of opioid (illicit drug) overdose deaths and diminishing access to prescription opioids and interventional techniques: cause and effect","volume":"25","author":"Manchikanti L","year":"2022","journal-title":"Pain Physician"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606\u2010019\u201005227\u20109"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.11013"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000000484"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m283"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.2196\/53625"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2024.108493"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.2196\/44726"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.josat.2024.209475"}],"container-title":["Journal of Healthcare Risk Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jhrm.21585","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T18:00:14Z","timestamp":1730829614000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jhrm.21585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,17]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1002\/jhrm.21585"],"URL":"https:\/\/doi.org\/10.1002\/jhrm.21585","archive":["Portico"],"relation":{},"ISSN":["1074-4797","2040-0861"],"issn-type":[{"type":"print","value":"1074-4797"},{"type":"electronic","value":"2040-0861"}],"subject":[],"published":{"date-parts":[[2024,10,17]]},"assertion":[{"value":"2024-05-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}